Clinical Trial Update: Vaccine for Recurrent Urinary Tract Infections in Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of a vaccine for recurrent urinary tract infections in women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Vaccine for recurrent urinary tract infections

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Recurrent Urinary Tract Infections in Women | Phase 2 | Status: COMPLETED